Your browser doesn't support javascript.
loading
Current vision on diagnosis and comprehensive care in hepatic encephalopathy.
Higuera-de-la-Tijera, F; Velarde-Ruiz Velasco, J A; Raña-Garibay, R H; Castro-Narro, G E; Abdo-Francis, J M; Moreno-Alcántar, R; Pérez-Hernández, J L; Torre, A; Contreras-Omaña, R; Cano-Contreras, A; Castillo-Barradas, M; Pérez-Escobar, J; Aldana-Ledesma, J M; Cerda-Reyes, E; Fernández-Pérez, N J; Meza-Cardona, J; Flores-García, N C; Reyes-Bastidas, M; Lira-Vera, J E; García-Jiménez, E S; Santana-Vargas, D; Páez-Zayas, V M; Chávez-Tapia, N C; Márquez-Guillén, E.
Afiliação
  • Higuera-de-la-Tijera F; Departamento de Gastroenterología y Hepatología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico. Electronic address: fatimahiguera@yahoo.com.mx.
  • Velarde-Ruiz Velasco JA; Departamento de Gastroenterología, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
  • Raña-Garibay RH; Hospital Español, Mexico City, Mexico.
  • Castro-Narro GE; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Abdo-Francis JM; Hospital Ángeles Acoxpa, Mexico City, Mexico.
  • Moreno-Alcántar R; Departamento de Gastroenterología, Hospital de Especialidades Bernardo Sepúlveda del Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
  • Pérez-Hernández JL; Departamento de Gastroenterología y Hepatología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico.
  • Torre A; Centro Médico ABC, Mexico City, Mexico.
  • Contreras-Omaña R; Centro de Educación e Investigación en Enfermedades Hepáticas y Toxicológicas (CEIHET), Pachuca, Hidalgo, Mexico.
  • Cano-Contreras A; Centro de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Veracruz, Mexico.
  • Castillo-Barradas M; Departamento de Gastroenterología, Hospital de Especialidades del Centro Médico Nacional "La Raza", IMSS, Mexico City, Mexico.
  • Pérez-Escobar J; Instituto Nacional de Enfermedades Respiratorias (INER) "Ismael Cosío Villegas", Mexico City, Mexico.
  • Aldana-Ledesma JM; Departamento de Gastroenterología, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
  • Cerda-Reyes E; Departamento de Gastroenterología, Hospital Central Militar, Mexico City, Mexico.
  • Fernández-Pérez NJ; Hospital Ángeles León, León, Guanajuato, Mexico.
  • Meza-Cardona J; Hospital Español, Mexico City, Mexico.
  • Flores-García NC; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Reyes-Bastidas M; Instituto Mexicano del Seguro Social, Culiacán, Sinaloa, Mexico.
  • Lira-Vera JE; Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico.
  • García-Jiménez ES; Departamento de Gastroenterología, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
  • Santana-Vargas D; Clínica de Trastornos del Sueño, Departamento de Medicina Experimental, Facultad de Medicina, UNAM, Mexico City, Mexico.
  • Páez-Zayas VM; Departamento de Gastroenterología y Hepatología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico.
  • Chávez-Tapia NC; Médica Sur, Mexico City, Mexico.
  • Márquez-Guillén E; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rev Gastroenterol Mex (Engl Ed) ; 88(2): 155-174, 2023.
Article em En | MEDLINE | ID: mdl-37127462
The first clinical guidelines on hepatic encephalopathy were published in 2009. Almost 14 years since that first publication, numerous advances in the field of diagnosis, treatment, and special condition care have been made. Therefore, as an initiative of the Asociación Mexicana de Gastroenterología A.C., we present a current view of those aspects. The manuscript described herein was formulated by 24 experts that participated in six working groups, analyzing, discussing, and summarizing the following topics: Definition of hepatic encephalopathy; recommended classifications; epidemiologic panorama, worldwide and in Mexico; diagnostic tools; conditions that merit a differential diagnosis; treatment; and primary and secondary prophylaxis. Likewise, these guidelines emphasize the management of certain special conditions, such as hepatic encephalopathy in acute liver failure and acute-on-chronic liver failure, as well as specific care in patients with hepatic encephalopathy, such as the use of medications and types of sedation, describing those that are permitted or recommended, and those that are not.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Rifaximina / Lactulose Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Rifaximina / Lactulose Idioma: En Ano de publicação: 2023 Tipo de documento: Article